Cingulate Inc. (NASDAQ:CINGW) Short Interest Down 96.3% in June

Cingulate Inc. (NASDAQ:CINGW) was the target of a significant drop in short interest in the month of June. As of June 15th, there was short interest totaling 402 shares, a drop of 96.3% from the May 31st total of 10,882 shares. Based on an average daily trading volume, of 13,143 shares, the short-interest ratio is currently 0.0 days.

Cingulate Stock Performance

Shares of NASDAQ CINGW remained flat at $0.02 during midday trading on Thursday. Cingulate has a 52 week low of $0.02 and a 52 week high of $0.17. The stock has a 50-day moving average price of $0.02 and a two-hundred day moving average price of $0.05.

Cingulate Company Profile

Cingulate Inc, a biopharmaceutical company, focuses on the development of pharmaceutical products for the treatment of attention deficit/hyperactivity disorder and anxiety in the United States. The company’s stimulant medications are CTx-1301 (dexmethylphenidate), which is in phase 3 clinical trial, as well as CTx-1302 (dextroamphetamine), which is in investigational new drug application development for the treatment of attention deficit/hyperactivity disorder intended for children, adolescents, and adults.